Bristol-Myers Squibb Company (NYSE: BMY) and Adnexus(TM) Therapeutics today announced a worldwide strategic alliance to discover, develop and commercialize Adnectin-based therapeutics for important oncology-related targets.
AstraZeneca announced the commencement of a new Phase III study of its new investigational once-daily orally administered drug, vandetanib (ZACTIMA(R), ZD6474).
Shire plc and its collaborative partner New River Pharmaceuticals Inc., announce the U.S. Food and Drug Administration has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of attention deficit hyperactivity disorder. VYVANSE is a prodrug that is therapeutically inactive until metabolized in the body.
Chronic kidney disease (CKD), a serious and progressive medical condition, has been and remains under-identified. While it is easy and inexpensive to test for kidney function, people who are at high risk for CKD are not routinely screened.
Industry-funded studies of breast cancer therapies are more likely to report positive results than non-pharmaceutical funded studies, researchers from the University of North Carolina at Chapel Hill and the Dana Farber Cancer Institute have found.
Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
African and African American women are more likely to die of breast cancer than their white counterparts because they tend to get the disease before the menopause, suggests new research from the University of East Anglia and the Children’s Hospital Boston in collaboration with researchers in the US and Italy.
A team of researchers at the University of Colorado at Boulder has developed a new technique to generate laser-like X-ray beams, removing a major obstacle in the decades-long quest to build a tabletop X-ray laser that could be used for biological and medical imaging.
A new study in rats reveals black soya beans that a diet rich in could help control weight, lower fat and cholesterol levels, and help in the prevention of diabetes. Researchers have shown that rats fed with 10 percent soya had gained half as much weight as those without. Total blood cholesterol fell by 25 percent and LDL (so-called bad) cholesterol fell by 60 percent. Preventing obesity this way may also aid diabetes prevention.
A once-a-day, short-term treatment with a drug compound substantially improved learning and memory in mice with Down syndrome symptoms, say researchers at the Stanford University School of Medicine and Lucile Packard Children?s Hospital.